Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD) (2025)
Iturbe-Rey, Santiago; Maccali, Claudia; Arrese, Marco; Aspichueta, Patricia; Oliveira, Claudia Pinto Marques Souza de 
; Castro, Rui E; Lapitz, Ainhoa; Izquierdo-Sanchez, Laura; Bujanda, Luis; Perugorria, Maria J
Source: Atherosclerosis. Unidade: FM
Subjects: HEPATOPATIAS, FATORES DE RISCO, METABOLISMO DE GORDURA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ITURBE-REY, Santiago et al. Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD). Atherosclerosis, v. 400, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/81950. Acesso em: 17 fev. 2026.APA
Iturbe-Rey, S., Maccali, C., Arrese, M., Aspichueta, P., Oliveira, C. P. M. S. de, Castro, R. E., et al. (2025). Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD). Atherosclerosis, 400. doi:10.1016/j.atherosclerosis.2024.119053NLM
Iturbe-Rey S, Maccali C, Arrese M, Aspichueta P, Oliveira CPMS de, Castro RE, Lapitz A, Izquierdo-Sanchez L, Bujanda L, Perugorria MJ. Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD) [Internet]. Atherosclerosis. 2025 ; 400[citado 2026 fev. 17 ] Available from: https://observatorio.fm.usp.br/handle/OPI/81950Vancouver
Iturbe-Rey S, Maccali C, Arrese M, Aspichueta P, Oliveira CPMS de, Castro RE, Lapitz A, Izquierdo-Sanchez L, Bujanda L, Perugorria MJ. Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD) [Internet]. Atherosclerosis. 2025 ; 400[citado 2026 fev. 17 ] Available from: https://observatorio.fm.usp.br/handle/OPI/81950
